Risk of Objectionable Microorganisms in Bio-Pharmaceutical Manufacturing


Carl Patterson, M.S. is Keynote Speaker at Compliance key Inc. He has completed twelve (12) plus years in the biotechnology, pharmaceutical manufacturing, and quality fields. He completed his Bachelor's of Science in Microbiology from the University of Texas. Also, has completed specialized certificates in biotechnology manufacturing, quality control, and quality assurance from UCSD, and has completed his Master's of Science in Biomedical Quality Systems from SDSU. Through the years, has worked with several companies in regards to aseptic processing and has helped to insure the expectations, r........

Overview

Objectionable microorganisms are considered,  if discovered, harmful to the patient. By identifying and controlling these microorganism and putting the appropriate controls place early in the pharmaceutical manufacturing or medical device manufacturing process problems in the patient can be prevented. This webinar will review the regulations pertaining to objectionable microorganisms, agency expectations, methods to identify objectionable microorganisms, interpreting results, and controls to put into place. By knowing, where, when,why, and how objectionable microorganisms exist, harmful consequences to the patient can be prevented.

Why should you attend this webinar?

Identifying objectionable microorganisms and putting the appropriate controls place early in the pharmaceutical manufacturing or medical device manufacturing process can prevent problems in the patient. This webinar will review the regulations pertaining to objectionable microorganisms, testing and identifying objectionable microorganisms, and putting appropriate controls into place to prevent harm to the patient.

Areas Covered in the Session:

  • Definition of objectionable microorganisms
  • Regulations pertaining to objectionable microorganisms
  • Identifying objectionable microorganisms
  • Tests to determine objectionable microorganisms
  • Sources of objectionable microorganisms
  •  Actions to reduce objectionable microorganism.

Who can Benefit:

Pharmaceutical Manufacturing and Medical Devices manufacturers



Webinar Id: LSHCCR002

Training Options:

Duration: 60 mins

 02/15/2018

 10:00 AM PT | 01:00 PM ET

 Single Attendee: [Only for one participant]

$179 (Live)                    $319 (Live + Recorded)

 Multiple Attendee: [For a group of 2-5 participants]

$368 (Live)                    $495 (Live + Recorded)

 Corporate Attendee: [For a group of 6-10 Participants]

$741 (Live)                    $1157 (Live + Recorded)

 Recorded: [Six month unlimited access]

$167 (Single Attendee) $599 (Unlimited Attendee)

Refund Policy
Past Webinar of Carl Patterson
Upcoming Webinar: Life Sciences and Healthcare
How to do a HIPAA Risk analysi....
By: Jonathan P. Tomes
When: 04/23/2018 | 10:00 AM PT |01:00 PM ET
Price: $179
FDA/EU MDSAP Inspections - Get....
By: Marie Dorat
When: 04/24/2018 | 12:30 PM PT |3:30 PM ET
Price: $179

More Webinar

Past Webinar: Life Sciences and Healthcare
HIPAA Compliant Messaging Plat....
By: Doug McMinn
View it anytime
Price: $167
Mobile Medical Apps (Is It an ....
By: Edwin Waldbusser
View it anytime
Price: $167

More Webinar

    
Copyright © 2018 Compliance Key . All Rights Reserved. Back to Top